(January 6, 2017, 7:19 AM EST) -- WASHINGTON, D.C. — A nonprofit association for generic drug product manufacturers and distributors argues in a Dec. 9 brief that the U.S. Supreme Court should review whether the Federal Circuit U.S. Court of Appeals erred in light of KSR International Co. v. Teleflex Inc. (550 U.S. 398, 415 [2007]) in restricting the Patent Trial and Appeal Board’s ability to rely on the common sense and common knowledge of skilled artisans to establish the obviousness of patent claims (Google Inc. and Motorola Mobility LLC v. Arendi S.A.R.L., et al., No. 16-626, U.S. Sup.)....